IMA Advisory Services’s Quest Diagnostics DGX Stock Holding History

IMA Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212	Hold	1	–	–	﹤0.01%	1338
2026 Q1	$195	Hold	1	–	–	﹤0.01%	965
2025 Q4	$173	Hold	1	–	–	﹤0.01%	962
2025 Q3	$191	Hold	1	–	–	﹤0.01%	506
2025 Q2	$180	Buy	+1	New	+$174	﹤0.01%	507

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

IMA Advisory Services's DGX Position: Q2 2026 in Review

IMA Advisory Services held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1 share worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

IMA Advisory Services first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

IMA Advisory Services held 1 share of Quest Diagnostics worth $212 as of Q2 2026.
IMA Advisory Services left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1338 holding.
IMA Advisory Services first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.